A record of what Abhishek Banerjee said publicly, with the source. Not advice.
Pending — not yet graded
“Pharma is facing significant challenges, particularly the threat of a 200% tariff on exports to the US, which accounts for 30-40% of revenues for most listed Indian pharma companies. This poses a substantial risk to the sector.”
Nifty PharmaBearishCalled 23 Jul 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Abhishek Banerjee’s full track record